Bioactivx^® has developed a  biomaterial platform technology that uses chemical synthesis know-how on tissue engineering and therapeutics. With technology patented in 2020 we have been working on robust pipeline to target various wound types and skin disease. Each product is carefully designed with clinicians to suit their clinical needs as a drop-in solution to existing clinical workflows. All products listed have completed pre-clinical studies with First-in-Human trials to commence in due course.

Platform Pipeline

Acute Wounds

• Bioactiv® Matrix (partial thickness wounds)
• Bioactiv® wound closure patch (surgical wound)
• Bioactiv® Foam (superficial and partial thickness wounds)

Chronic Wounds

• Bioactiv® Foam
• Bioactiv® packing ribbon
• Bioactiv® anti-microbial foam and packing ribbon

Bone Defect Repair

• Bioactiv® Bone Pellets
• Bioactiv® Bone Wedge

Skin Disease

• Anti-inflammatory gel for Atopic Dermatitis